A detailed history of Sherman Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Sherman Asset Management, Inc. holds 1,418 shares of ABT stock, worth $184,382. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,418
Previous 2,212 35.9%
Holding current value
$184,382
Previous $301 Million 36.88%
% of portfolio
0.16%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$120.51 - $136.62 $95,684 - $108,476
-794 Reduced 35.9%
1,418 $190 Million
Q1 2025

Apr 14, 2025

SELL
$111.1 - $140.22 $777 - $981
-7 Reduced 0.32%
2,212 $293 Million
Q4 2024

Feb 05, 2025

BUY
$111.93 - $119.39 $248,372 - $264,926
2,219 New
2,219 $251 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sherman Asset Management, Inc. Portfolio

Follow Sherman Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherman Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sherman Asset Management, Inc. with notifications on news.